Huberman Lab discussions of BPC-157 and recovery peptides, translated into research context - mechanism framing, evidence caveats and the compounds listeners search next. Public commentary, not endorsement.

Sylvester Stallone and peptides: what the longevity-clinic coverage says

Lifestyle press has linked Stallone to specialised longevity clinics in the Hollywood peptide wave - what that association actually means, and the research categories clinics usually name. Press coverage, not endorsement.

What is the Wolverine stack? BPC-157 + TB-500 explained

The canonical sourced explainer for the BPC-157 + TB-500 recovery pairing popularised by Joe Rogan and Josh Duhamel - cultural nickname, research context, not a protocol.

Athletes and peptides in 2026: the sport-by-sport research map

How peptide-recovery research maps onto golf, Hyrox, CrossFit, MMA, marathon, cycling, powerlifting and bodybuilding - BPC-157, TB-500, MOTS-c and the WADA reality every competitor needs.

TikTok Peptide Sellers: How to Spot Hype, Resellers and Quick-Buck Marketing

Viral peptide videos do not equal credible suppliers. How to see past parcels, luxury cars and "selling out fast" urgency - reselling, affiliate links and follower counts - and the evidence-based questions (independent testing, CoAs, transparency) to ask a research-compound supplier instead. Research use only.

Hailey Bieber and peptides: why GHK-Cu and BPC-157 are making headlines

What ELLE reported Hailey Bieber said - GHK-Cu, BPC-157, oral vs injectable, skin, hair and nails - with the research context behind each compound. Press coverage, not endorsement.

Bryan Johnson's CJC-1295 experiment: what his 2026 results showed

The skeptical data point - a measured CJC-1295 self-experiment with reported adverse markers, and the argument that peptides are “not only good.” His public account with the research context.

Joe Rogan and BPC-157: how the “Wolverine stack” became famous

The podcast exchange, the New Yorker feature and the BPC-157 + TB-500 research context behind the recovery-peptide trend Rogan did so much to accelerate. Press coverage, not endorsement.

Jennifer Aniston and peptide therapy: why Hollywood is talking about longevity

The anti-aging and longevity framing that outlets like E! News, ELLE and The Independent tracked through 2026 - and what the research actually supports. Press coverage, not endorsement.

Khloé Kardashian says peptides changed her life: what has she actually revealed?

Separating the “changed my life” headline from the specifics - what ELLE and AOL actually reported about daily peptide injections, and why the specific compound matters. Press coverage, not endorsement.

Gwyneth Paltrow's peptide and NAD+ routine: celebrity claims vs research

What ELLE reported about Paltrow discussing NAD+ drips and peptide shots - set against what the NAD+ research literature actually shows. Press coverage, not endorsement.

Josh Duhamel and the Wolverine stack: why BPC-157 and TB-500 are trending

The actor who put a face on the BPC-157 + TB-500 recovery pairing, per ELLE and AOL - with the research context behind the two compounds. Press coverage, not endorsement.

Frank Grillo and BPC-157: why recovery peptides are trending in Hollywood

The action star who has publicly credited BPC-157 with recovery, per AOL and ELLE - with what the BPC-157 research literature establishes and what it does not. Press coverage, not endorsement.

LeAnn Rimes and peptide injections: inside the celebrity wellness trend

The name Yahoo and ELLE credited with helping drive the “anti-aging peptide shot” trend - with the research context behind the category. Press coverage, not endorsement.

Celebrity peptide claims vs scientific research: what is actually known?

A four-tier framework for reading 2026 headlines - public statement vs approved medicine vs preliminary research compound vs promotional claim - so a famous name never stands in for evidence.

The Unregulated Peptide Grey Market: What the Telegraph Investigation Reveals

A Telegraph investigation describes men and women self-injecting unregulated peptides bought from influencers and grey-market sellers. What the report found, why "research use only" is a legal line and not a green light for human use, and why third-party purity testing matters. Research use only.

Trump, Retatrutide and the Obesity-Drug Demand Story

The White House denies that Donald Trump got early compassionate-use access to retatrutide, an experimental obesity drug still in Eli Lilly trials. What the story says, what compassionate use is, why retatrutide is not approved before 2027, and why research use only is a separate category from human use.

Why Reta Searches Are Surging in the USA: A 2026 Search-Trend Report

US search interest in retatrutide ("reta", LY3437943) has gone from near-zero to a Google Trends Breakout term since 2023. What is driving the surge, what the data does and does not mean, and how US researchers source it. Search-interest data only - research use only.

The Rising Demand for Research Peptides in the UK: A 2026 Search-Trend Report

UK search interest in research peptides - GLP-1 compounds, BPC-157, GHK-Cu and more - has climbed sharply since 2023. What UK researchers search for, why, the MHRA framing, and how the research-use market works. Search-interest data only - research use only.

Research Peptide Search Demand in the USA: A 2026 Trend Report

US search interest in research peptides surged through the GLP-1 era and the FDA compounding shake-up. What American researchers search for, why, the FDA framing, and how the research-use market works. Search-interest data only - research use only.

Peptide Search Demand in Australia: A 2026 Trend Report

Australian search interest in research peptides has climbed sharply, led by GLP-1 compounds. What Australian researchers search for, why, the TGA framing, and how the research-use market works. Search-interest data only - research use only.

Is Retatrutide Safe? What the Research and the Safety Warnings Actually Show

After 2026 news reports of retatrutide ("reta") being sold online despite its unapproved status, what the research actually shows on safety: the Phase 2 adverse-event picture (dose-dependent GI effects, a heart-rate signal), the long-term unknowns, why self-sourcing is the real risk, and the research-use-only line.

GLP-1 Access Is Becoming a Coverage Problem

With Cigna dropping GLP-1 obesity coverage for its own plan, access and affordability are now separate from the science. A neutral look at the market shift.

Why peptides could become the next big mainstream health news story

Peptides such as BPC-157, TB-500, Semax and Epitalon are moving from niche research circles into mainstream health news as the FDA prepares its July 2026 compounding review. Why it matters - and how to read the coverage responsibly, because a review is not an approval.

Peptides, the FDA and the media: what viewers need to understand

As peptides become a bigger public-health story around the FDA's July 2026 review, audiences need clearer information about BPC-157, TB-500, Semax, Epitalon and the 503A Bulks List. A plain-English guide to reading the coverage - FDA review is not FDA approval.

Celebrities and peptides in 2026: the sourced list

Hailey Bieber, Jennifer Aniston, Khloé Kardashian, Gwyneth Paltrow, Joe Rogan, Bryan Johnson, Andrew Huberman and Sylvester Stallone - BPC-157, GHK-Cu, CJC-1295, NAD+ and the “Wolverine stack,” every quote attributed. Reporting on press coverage, not endorsement.

Inside the private clinics: protocols of the top 1%

The compounds Silicon Valley founders and A-list actors have cycled through for over a decade in $30,000-a-year longevity clinics - and how direct-to-researcher access changes the equation.

Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.

Browse the full catalogue

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research

Support

Ways to Pay

Shop by goal

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Shop by compound

CJC-1295 (without DAC)

Shop by region

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.